Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 2Withdrawn 1Terminated 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Prostatic Neoplasms 80Breast Neoplasms 39Neoplasms 6Neoplasm Metastasis 4Leiomyoma 2Infertility 2Breast Neoplasms, Male 2Stage I Prostate Adenocarcinoma AJCC v7 1Sexual Dysfunction, Physiological 1Sarcopenia 1Salivary Gland Neoplasms 1Recurrence 1Primary Dysautonomias 1Patient Compliance 1Ovarian Neoplasms 1Osteoporosis 1Osteitis Deformans 1Lymphatic Metastasis 1Kidney Diseases 1Hypertension 1Hyperlipidemias 1Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer 1Hodgkin Disease 1Hereditary Sensory and Autonomic Neuropathies 1Hemorrhage 1Fallopian Tube Neoplasms 1Castrate Sensitive Prostate Cancer 1Carcinoma, Ovarian Epithelial 1Bulbo-Spinal Atrophy, X-Linked 1Advanced Prostate Cancer 1

Interventions

Trastuzumab 25Paclitaxel 22Cyclophosphamide 20Docetaxel 17Taxes 14Lapatinib 13Doxorubicin 13Radiotherapy 12Bevacizumab 11Capecitabine 10Tamoxifen 9Immunohistochemistry 9sargramostim 8Granulocyte-Macrophage Colony-Stimulating Factor 8Filgrastim 8Carboplatin 8Vorinostat 6Magnetic Resonance Spectroscopy 6Erlotinib Hydrochloride 6Chemotherapy, Adjuvant 6Biopsy 6Peripheral Blood Stem Cell Transplantation 5Everolimus 5liposomal doxorubicin 4ixabepilone 4Vinorelbine 4Neoadjuvant Therapy 4Immunoenzyme Techniques 4Gene Expression Profiling 4Fluorodeoxyglucose F18 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms, Male × Goserelin × Clear all
NCT02586675 2022-01-21

TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
7 enrolled 8 charts
Breast

Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

NCT01638247 2018-09-19

MALE

GBG Forschungs GmbH

Phase 3 Completed
56 enrolled
Breast

Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡